Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Non-Current Assets came in at $188000.0 in Q1 2026, down 66.9% year-over-year from $568000.0 in Q1 2025, and down 42.68% quarter-over-quarter from $328000.0 in Q4 2025.
Analysis
Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Non-Current Assets across 5 years of filings, most recently posting $188000.0 for Q1 2026.
- In Q1 2026, Non-Current Assets fell 66.9% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 50.04% YoY), while the FY2025 annual figure was $485000.0, down 42.6% from the prior year.
- Non-Current Assets came in at $188000.0 for Q1 2026 at Incannex Healthcare, down from $328000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $53.1 million in Q4 2022 to a low of $188000.0 in Q1 2026.
- Average Non-Current Assets over 5 years is $5.0 million, with a median of $694000.0 recorded in 2023.
- Year-over-year, Non-Current Assets plunged 98.07% in 2023 and climbed 7.51% in 2024.
- Over 5 years, Non-Current Assets stood at $53.1 million in 2022, then sank by 98.07% to $1.0 million in 2023, then slumped by 41.38% to $602000.0 in 2024, then tumbled by 45.51% to $328000.0 in 2025, then slumped by 42.68% to $188000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $188000.0 in Q1 2026, $328000.0 in Q4 2025, and $425000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | 294.93 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 3.74 Bn |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | 188,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 328,000.00 |
| Sep 30, 2025 | 425,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 568,000.00 |
| Dec 31, 2024 | 602,000.00 |
| Sep 30, 2024 | 839,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 931,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Jun 30, 2023 | 786,000.00 |
| Dec 31, 2022 | 53.09 Mn |